Telomir Pharmaceuticals, Inc. - COM (TELO)

Historical Portfolio Holders from Q1 2024 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
2.05M
Holdings value Q3 2024
$13.1M
Value change Q3 2024
+$9.01M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
33
Number of buys Q3 2024
20
Number of sells Q3 2024
-5
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.05M $13.1M +$9.01M $6.42 33
2024 Q2 361K $1.74M +$1.33M $4.81 24
2024 Q1 79.9K $413K +$413K $5.15 7